BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34289567)

  • 1. [Progress in diagnosis and treatment of lung adenocarcinomas imaging manifesting as radiological part-solid nodule].
    Bai GY; Qiu B; Ji Y; Song P; Zhang F; Xue Q; Gao SG
    Zhonghua Zhong Liu Za Zhi; 2021 Jul; 43(7):743-750. PubMed ID: 34289567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype.
    Ye T; Deng L; Wang S; Xiang J; Zhang Y; Hu H; Sun Y; Li Y; Shen L; Xie L; Gu W; Zhao Y; Fu F; Peng W; Chen H
    J Thorac Oncol; 2019 Apr; 14(4):617-627. PubMed ID: 30659988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic features and lymph node metastatic characteristics in patients with adenocarcinoma manifesting as part-solid nodule exceeding 3 cm in diameter.
    Li W; Zhou F; Wan Z; Li M; Zhang Y; Bao X; Zhang L; Shi J
    Lung Cancer; 2019 Oct; 136():37-44. PubMed ID: 31437662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma.
    Miyoshi T; Aokage K; Katsumata S; Tane K; Ishii G; Tsuboi M
    Ann Thorac Surg; 2019 Jul; 108(1):249-255. PubMed ID: 30876742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid Components in the Mediastinal Window of Computed Tomography Define a Distinct Subtype of Subsolid Nodules in Clinical Stage I Lung Cancers.
    Yin J; Xi J; Liang J; Zhan C; Jiang W; Lin Z; Xu S; Wang Q
    Clin Lung Cancer; 2021 Jul; 22(4):324-331. PubMed ID: 33789831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of Invasive Lung Adenocarcinoma Based on Chest CT Radiomic Features of Part-Solid Pulmonary Nodules: A Multicenter Study.
    Wu G; Woodruff HC; Shen J; Refaee T; Sanduleanu S; Ibrahim A; Leijenaar RTH; Wang R; Xiong J; Bian J; Wu J; Lambin P
    Radiology; 2020 Nov; 297(2):451-458. PubMed ID: 32840472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT Screening for Lung Cancer: Part-Solid Nodules in Baseline and Annual Repeat Rounds.
    Henschke CI; Yip R; Smith JP; Wolf AS; Flores RM; Liang M; Salvatore MM; Liu Y; Xu DM; Yankelevitz DF;
    AJR Am J Roentgenol; 2016 Dec; 207(6):1176-1184. PubMed ID: 27726410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of Multiple Solid Portions in Part-Solid Nodules for T Categorization: Evaluation of Prognostic Implication.
    Kim H; Goo JM; Suh YJ; Hwang EJ; Park CM; Kim YT
    J Thorac Oncol; 2018 Dec; 13(12):1864-1872. PubMed ID: 30292849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for lymph node metastasis and surgical methods in patients with early-stage peripheral lung adenocarcinoma presenting as ground glass opacity.
    Wang Y; Jing L; Wang G
    J Cardiothorac Surg; 2020 Aug; 15(1):121. PubMed ID: 32782020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients.
    Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
    Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of total tumor size on the prognosis of patients with clinical stage IA lung adenocarcinomas appearing as part-solid nodules: Does only the solid portion size matter?
    Kim H; Goo JM; Suh YJ; Park CM; Kim YT
    Eur Radiol; 2019 Mar; 29(3):1586-1594. PubMed ID: 30132107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Ground-Glass Opacities in the Lung Cancer Spectrum.
    Zhang Y; Fu F; Chen H
    Ann Thorac Surg; 2020 Dec; 110(6):1796-1804. PubMed ID: 32525031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous computed tomography guided biopsy of sub-solid pulmonary nodules: differentiating solid from ground glass components at the time of biopsy.
    Halpenny D; Das K; Ziv E; Plodkowski A; Zheng J; Capanu M; Rekhtman N; Montecalvo J; Solomon SB; Ginsberg MS
    Clin Imaging; 2021 Jan; 69():332-338. PubMed ID: 33059184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Eighth Edition Clinical T Categorization System for Clinical Stage IA, Resected Lung Adenocarcinomas: Prognostic Implications of the Ground-Glass Opacity Component.
    Kim H; Goo JM; Kim YT; Park CM
    J Thorac Oncol; 2020 Apr; 15(4):580-588. PubMed ID: 31877384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial.
    Yip R; Henschke CI; Xu DM; Li K; Jirapatnakul A; Yankelevitz DF
    AJR Am J Roentgenol; 2017 May; 208(5):1011-1021. PubMed ID: 28245151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of late-phase contrast enhancement on semi-automatic software measurements of CT attenuation and volume of part-solid nodules in lung adenocarcinomas.
    Cohen JG; Goo JM; Yoo RE; Park SB; van Ginneken B; Ferretti GR; Lee CH; Park CM
    Eur J Radiol; 2016 Jun; 85(6):1174-80. PubMed ID: 27161068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications.
    Lee HY; Lee KS
    J Thorac Imaging; 2011 May; 26(2):106-18. PubMed ID: 21508733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should resection extent be decided by total lesion size or solid component size in ground glass opacity-containing lung adenocarcinomas?
    Lin B; Wang R; Chen L; Gu Z; Ji C; Fang W
    Transl Lung Cancer Res; 2021 Jun; 10(6):2487-2499. PubMed ID: 34295656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma.
    Zhou J; Li Y; Zhang Y; Liu G; Tan H; Hu Y; Xiao J; Shi H
    Oncotarget; 2017 Apr; 8(14):23312-23321. PubMed ID: 28423576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HRCT features differentiate synchronous multiple primary lung adenocarcinomas from intrapulmonary metastases].
    Zhou LN; Wu N; Zhao SJ; Yang L; Wang YL; Wang RB; Yang SX
    Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):449-455. PubMed ID: 32575939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.